Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices 39783 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

1The record is defined in sec. 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2 83 FR 29092 (June 22, 2018). Whether 

establishment of an industry in the United States 

is materially retarded is not an issue in this 

investigation. 

3Commissioner Rhonda K. Schmidtlein 

dissenting. Commissioner Jason E. Kearns did not 

Continued 

SUPPLEMENTARY INFORMATION: The 

Commission has received a complaint 

and a submission pursuant to § 210.8(b) 

of the Commission’s Rules of Practice 

and Procedure filed on behalf of Sipco 

LLC on August 6, 2018. The complaint 

alleges violations of section 337 of the 

Tariff Act of 1930 (19 U.S.C. 1337) in 

the importation into the United States, 

the sale for importation, and the sale 

within the United States after 

importation of certain wireless mesh 

networking products and related 

components thereof. The complaint 

names as respondents: Emerson Electric 

Co. of St. Louis, MO; Emerson Process 

Management LLLP of Bloomington, MN; 

Emerson Process Management Asia 

Pacific Private Limited of Singapore; 

Emerson Process Management 

Manufacturing (M) Sdn. Bhd. of 

Malaysia; Fisher-Rosemount Systems, 

Inc. of Round Rock, TX; Rosemount Inc. 

of Shakaopee, MN; Analog Devices, Inc. 

of Norwood, MA; Linear Technology 

LLC of Milpitas, CA; Dust Networks, 

Inc. of Union City, CA; Tadiran Batteries 

Inc. of Lake Success, NY; and Tadiran 

Batteries Ltd. of Israel. The complainant 

requests that the Commission issue a 

limited exclusion order, cease and 

desist orders and impose a bond during 

the 60-day review period pursuant to 19 

U.S.C. 1337(j). 

Proposed respondents, other 

interested parties, and members of the 

public are invited to file comments, not 

to exceed five (5) pages in length, 

inclusive of attachments, on any public 

interest issues raised by the complaint 

or § 210.8(b) filing. Comments should 

address whether issuance of the relief 

specifically requested by the 

complainant in this investigation would 

affect the public health and welfare in 

the United States, competitive 

conditions in the United States 

economy, the production of like or 

directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the requested 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the requested remedial 

orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the requested 

exclusion order and/or a cease and 

desist order within a commercially 

reasonable time; and 

(v) explain how the requested 

remedial orders would impact United 

States consumers. 

Written submissions on the public 

interest must be filed no later than by 

close of business, eight calendar days 

after the date of publication of this 

notice in the Federal Register. There 

will be further opportunities for 

comment on the public interest after the 

issuance of any final initial 

determination in this investigation. Any 

written submissions on other issues 

should be filed no later than by close of 

business nine calendar days after the 

date of publication of this notice in the 

Federal Register. Complainant may file 

a reply to any written submission no 

later than the date on which 

complainant’s reply would be due 

under § 210.8(c)(2) of the Commission’s 

Rules of Practice and Procedure (19 CFR 

210.8(c)(2)). 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above and submit 8 true paper 

copies to the Office of the Secretary by 

noon the next day pursuant to § 210.4(f) 

of the Commission’s Rules of Practice 

and Procedure (19 CFR 210.4(f)). 

Submissions should refer to the docket 

number (‘‘Docket No. 3333’’) in a 

prominent place on the cover page and/ 

or the first page. (See Handbook for 

Electronic Filing Procedures, Electronic 

Filing Procedures 1). Persons with 

questions regarding filing should 

contact the Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All such requests 

should be directed to the Secretary to 

the Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: August 6, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–17116 Filed 8–9–18; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–1380 (Final)] 

Tapered Roller Bearings From Korea 

Determination 

On the basis of the record 1 developed 

in the subject investigation, the United 

States International Trade Commission 

(‘‘Commission’’) determines, pursuant 

to the Tariff Act of 1930 (‘‘the Act’’), 

that an industry in the United States is 

not materially injured or threatened 

with material injury by reason of 

imports of tapered roller bearings from 

Korea that have been found by the U.S. 

Department of Commerce (‘‘Commerce’’) 

to be sold in the United States at less 

than fair value (‘‘LTFV’’).2 3


daltland on DSKBBV9HB2PROD with NOTICES
39784 Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices 

participate in the determination in this 

investigation. 

1There is no corrective action plan, or indication 

that Respondent submitted a corrective action plan, 

in the record before me. 

Background 

The Commission, pursuant to section 

735(b) of the Act (19 U.S.C. 1673d(b)), 

instituted this investigation effective 

June 28, 2017, following receipt of a 

petition filed with the Commission and 

Commerce by The Timken Company, 

North Canton, Ohio. The Commission 

scheduled the final phase of the 

investigation following notification of a 

preliminary determination by 

Commerce that imports of tapered roller 

bearings from Korea were being sold at 

LTFV within the meaning of section 

733(b) of the Act (19 U.S.C. 1673b(b)). 

Notice of the scheduling of the final 

phase of the Commission’s investigation 

and of a public hearing to be held in 

connection therewith was given by 

posting copies of the notice in the Office 

of the Secretary, U.S. International 

Trade Commission, Washington, DC, 

and by publishing the notice in the 

Federal Register of February 27, 2018 

(83 FR 8504). The hearing was held in 

Washington, DC, on June 5, 2018, and 

all persons who requested the 

opportunity were permitted to appear in 

person or by counsel. 

The Commission made this 

determination pursuant to section 

735(b) of the Act (19 U.S.C. 1673d(b)). 

It completed and filed its determination 

in this investigation on August 6, 2018. 

The views of the Commission are 

contained in USITC Publication 4806 

(August 2018), entitled Tapered Roller 

Bearings from Korea: Investigation No. 

731–TA–1380 (Final). 

By order of the Commission. 

Issued: August 6, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–17125 Filed 8–9–18; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[USITC SE–18–036] 

Government in the Sunshine Act 

Meeting Notice 

AGENCY HOLDING THE MEETING: United 

States International Trade Commission. 

TIME AND DATE: August 24, 2018 at 9:00 

a.m. 

PLACE: Room 101, 500 E Street SW, 

Washington, DC 20436, Telephone: 

(202) 205–2000. 

STATUS: Open to the public. 

MATTERS TO BE CONSIDERED: 

1. Agendas for future meetings: None. 

2. Minutes. 

3. Ratification List. 

4. Vote on Inv. Nos. 731–TA–678–679 

and 681–682 (Fourth Review) (Stainless 

Steel Bar from Brazil, India, Japan, and 

Spain). The Commission is currently 

scheduled to complete and file its 

determinations and views of the 

Commission by September 11, 2018. 

5. Outstanding action jackets: None. 

In accordance with Commission 

policy, subject matter listed above, not 

disposed of at the scheduled meeting, 

may be carried over to the agenda of the 

following meeting. 

By order of the Commission. 

Issued: August 7, 2018. 

William Bishop, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2018–17260 Filed 8–8–18; 11:15 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Bharanidharan Padmanabhan, M.D., 

Ph.D.; Decision and Order 

On October 20, 2017, the Acting 

Assistant Administrator, Diversion 

Control Division, Drug Enforcement 

Administration (hereinafter, DEA or 

Government), issued an Order to Show 

Cause to Bharanidharan Padmanabhan, 

M.D., Ph.D. (hereinafter, Respondent), of 

Brookline, Massachusetts. Order to 

Show Cause (hereinafter, OSC), at 1. 

The Show Cause Order proposes the 

revocation of Respondent’s Certificate of 

Registration on the ground that he does 

‘‘not have authority to handle controlled 

substances in the Commonwealth of 

Massachusetts, the state in which . . . 

[he is] registered with the DEA.’’ Id. at 

1 (citing 21 U.S.C. 823(f) and 824(a)(3)). 

Regarding jurisdiction, the Show 

Cause Order alleges that Respondent 

holds DEA Certificate of Registration 

No. BP7993290 at the registered address 

of 30 Gardner Road #6A, Brookline, 

Massachusetts 02445. OSC, at 1. This 

registration authorizes Respondent to 

dispense controlled substances in 

schedules II through V as a practitioner. 

The Show Cause Order alleges that this 

registration expires on March 31, 2020. 

Id. 

The substantive ground for the 

proceeding, as alleged in the Show 

Cause Order, is that Respondent is 

‘‘without authority to handle controlled 

substances in the Commonwealth of 

Massachusetts, the state in which . . . 

[he is] registered . . . with the DEA.’’ Id. 

at 1. Specifically, the Show Cause Order 

alleges that the Massachusetts ‘‘Board of 

Registration in Medicine Indefinitely 

Suspended . . . [Respondent’s] medical 

license’’ on May 11, 2017, and that this 

indefinite suspension ‘‘became effective 

on July 11, 2017 and remains in effect.’’ 

Id. 

The Show Cause Order notifies 

Respondent of his right to request a 

hearing on the allegations or to submit 

a written statement while waiving his 

right to a hearing, the procedures for 

electing each option, and the 

consequences for failing to elect either 

option. Id. at 2 (citing 21 CFR 1301.43). 

The Show Cause Order also notifies 

Respondent of the opportunity to 

submit a corrective action plan. OSC, at 

2–3 (citing 21 U.S.C. 824(c)(2)(C)). 

By letter dated November 13, 2017, 

Respondent requested a hearing. 

Hearing Request, at 1. According to the 

Hearing Request, Respondent ‘‘wish[es] 

to show why . . . [he] should retain’’ 

Certificate of Registration No. 

BP7993290. Id. Respondent’s Hearing 

Request refers to the ‘‘alleged’’ action of 

the Massachusetts Board of Registration 

in Medicine (hereinafter, Massachusetts 

Board) ‘‘indefinitely suspending . . . 

[his] license’’ as ‘‘corrupt and legally 

void,’’ and states his ‘‘position [to be] 

that DEA must hold all action in 

abeyance till the federal courts have 

ruled on the unlawfulness of the 

racketeers’ action in May 2017.’’ Id. at 

2.1

The Office of Administrative Law 

Judges put the matter on the docket and 

assigned it to Administrative Law Judge 

Mark M. Dowd (hereinafter, ALJ). I 

adopt the following statement of 

procedural history from the ALJ’s Order 

Denying The Respo[n]dent’s Request for 

Abeyance, Granting the Government’s 

Motion for Summary Disposition, and 

Recommended Rulings, Findings of 

Fact, Conclusions of Law, and Decision 

of the Administrative Law Judge dated 

January 26, 2018 (hereinafter, R.D.). 

On November 20, 2017, this tribunal 

ordered the Government to file evidence to 

support the allegations that the Respondent 

lacked state authority to handle controlled 

substances. 

On December 4, 2017, the Government 

filed a Motion for Summary Disposition 

. . . . The Government submitted evidence 

that the Commonwealth of Massachusetts 

Board of Registration in Medicine 

indefinitely suspended the Respondent’s 

medical license on May 11, 2017, in the form 

of the Final Decision and Order from 

Commonwealth of Massachusetts Board of 

Registration . . . . Gov’t Mot. at Ex. 2, a. The 

Suspension was stayed for sixty days [a 

period which has since expired] to allow the 


daltland on DSKBBV9HB2PROD with NOTICES